ESSDAI activity index of the SJoGRENSER cohort: analysis and comparison with other European cohorts


Por: Rosas, J, Sanchez-Piedra, C, Fernandez-Castro, M, Andreu, JL, Martinez-Taboada, V, Olive, A, Menor, R, Rodriguez, B, Aparicio, AG, Longo, FJL, Manrique-Arija, S, Vadillo, JAG, Barato, SG, Lopez-Gonzalez, R, Narvaez, FJ, Galisteo, C, Martin, JG, Lucea, ER, Naranjo, A, Erausquin, C, Rua-Figueroa, I, Illera, O, Romani, L, Melchor, S, Moreira, B, Raya, E, Lopez, MR, Mourino, C, Pego, JM, Cid, N, Judez, E, Moriano, C, Torrente, V, Corominas, H, Magallon, BG, Astete, CG, Castellvi, I, Bohorquez, C, Loricera, J, Belzunegui, J and Cobo, T

Publicada: 1 jun 2019 Ahead of Print: 19 mar 2019
Resumen:
The objective of the study was to assess the ESSDAI index characteristics in the SJoGRENSER cohort (Spanish Rheumatology Association's registry of patients with Primary Sjogren Syndrome [PSS]). SJoGRENSER is a prospective multicentric study on a cohort of Spanish patients with PSS who meet the 2002 American-European consensus from rheumatology units. 298 variables were studied in patients for the inclusion of the study from an anonymous list from each department. The ESSDAI (EULAR Sjogren's syndrome disease activity index) includes 12 domains and measures systematic activity in PSS patients. Each domain is divided into 3-4 levels, (0: no activity; 1: low activity; 2: moderate activity; 3: high activity) and is attributed a weight. Each domain score is obtained by multiplying the activity level by the weight assigned. According to ESSDAI: low activity<5; moderate activity 5-13, and high activity14. ESSDAI was compared between several European PSS cohorts (EULAR, ASSES, GEAS, GRISS, Ducth). 437 patients were included from 33 Spanish rheumatology units. 95.2% were women with a median age of 58.63years [p25-p75: 50.02-67.98 years] and average PSS evolution of 10.4years (6-16years). ESSDAI median on entering the study was 2 (0-4). 31% of patients had ESSDAI 0; low activity 49%, moderate activity 15%, and high activity 5%. Those with greater activity were the joint, haematological and biological domains, whereas the lung was the most affected organ with pleural and parenchymatous involvement. Unlike other European cohorts, the initial SJoGRENSER cohort was characterised by low-zero systemic activity in 80% of patients, which differentiates it from other cohorts and provides a prospective study opportunity.

Filiaciones:
Rosas, J:
 Hosp Marina Baixa, Dept Rheumatol, Alicante, Spain

Sanchez-Piedra, C:
 Spanish Soc Rheumatol, Res Unit, Madrid, Spain

Fernandez-Castro, M:
 Hosp Univ Puerta de Hierro Majadahonda, Dept Rheumatol, Madrid, Spain

Andreu, JL:
 Hosp Univ Puerta de Hierro Majadahonda, Dept Rheumatol, Madrid, Spain

Martinez-Taboada, V:
 Hosp Marques de Valdecilla, Dept Rheumatol, Santander, Spain

 Univ Cantabria, Fac Med, Santander, Spain

:
 Hosp Badalona Germans Trias & Pujol, Dept Rheumatol, Barcelona, Spain

Menor, R:
 Hosp Gen Jerez de la Frontera, Jerez de la Frontera, Spain

Rodriguez, B:
 Hosp Univ Canarias, Santa Cruz De Tenerife, Spain

Aparicio, AG:
 Hosp Virgen Salud, Toledo, Spain

Longo, FJL:
 Hosp Gregorio Maranon, Madrid, Spain

Manrique-Arija, S:
 Hosp Carlos Haya, Malaga, Spain

Vadillo, JAG:
 Hosp La Princesa, Madrid, Spain

Barato, SG:
 Hosp Gen Alicante, Alicante, Spain

Lopez-Gonzalez, R:
 Hosp Virgen de la Concha, Zamora, Spain

Narvaez, FJ:
 Hosp Bellvitge Princeps Espanya, Barcelona, Spain

Galisteo, C:
 Hosp Parc Tauli, Sabadell, Spain

Martin, JG:
 Hosp Madrid Norte Sanchinarro, Madrid, Spain

Lucea, ER:
 Hosp Basurto, Basurto, Spain

Naranjo, A:
 Hosp Doctor Negrin, Las Palmas Gran Canaria, Spain

Erausquin, C:
 Hosp Doctor Negrin, Las Palmas Gran Canaria, Spain

Rua-Figueroa, I:
 Hosp Doctor Negrin, Las Palmas Gran Canaria, Spain

Illera, O:
 Hosp Infanta Sofia, Madrid, Spain

Romani, L:
 Hosp Virgen de las Nieves, Granada, Spain

Melchor, S:
 Hosp Doce Octubre, Madrid, Spain

Moreira, B:
 Hosp Sierrallana, Torrelavega, Spain

Raya, E:
 Hosp Clin San Cecilio, Granada, Spain

Lopez, MR:
 Hosp Meixoeiro, Vigo, Spain

Mourino, C:
 Hosp Meixoeiro, Vigo, Spain

Pego, JM:
 Hosp Meixoeiro, Vigo, Spain

Cid, N:
 Hosp Valme, Seville, Spain

Judez, E:
 Hosp Albacete, Albacete, Spain

Moriano, C:
 Hosp Leon, Leon, Spain

Torrente, V:
 Hosp LHospitalet, Lhospitalet De Llobregat, Spain

Corominas, H:
 Hosp St Joan Despi Moises Broggi, Barcelona, Spain

Magallon, BG:
 Hosp Miguel Servet, Zaragoza, Spain

Astete, CG:
 Hosp Ramon & Cajal, Madrid, Spain

Castellvi, I:
 Hosp San Pau & Santa Creu, Barcelona, Spain

Bohorquez, C:
 Hosp Principe Asturias, Alcala De Henares, Spain

Loricera, J:
 Hosp Marques de Valdecilla, Santander, Spain

Belzunegui, J:
 Hosp Donostia, Gipuzkoa, Spain

Cobo, T:
 Hosp Infanta Sofia, Madrid, Spain
ISSN: 01728172





Rheumatology International
Editorial
Springer Verlag, TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY, Alemania
Tipo de documento: Article
Volumen: 39 Número: 6
Páginas: 991-999
WOS Id: 000467497400004
ID de PubMed: 30891620

MÉTRICAS